Eliem Therapeutics ELYM Stock
Eliem Therapeutics Price Chart
Eliem Therapeutics ELYM Financial and Trading Overview
| Eliem Therapeutics stock price | 4.31 USD |
| Previous Close | 3 USD |
| Open | 2.96 USD |
| Bid | 0 USD x 1400 |
| Ask | 0 USD x 3200 |
| Day's Range | 2.82 - 2.96 USD |
| 52 Week Range | 2.21 - 4.75 USD |
| Volume | 8.9K USD |
| Avg. Volume | 6.46K USD |
| Market Cap | 76.12M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.3 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.5 USD |
ELYM Valuation Measures
| Enterprise Value | -27707496 USD |
| Trailing P/E | N/A |
| Forward P/E | -4.0285716 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.65096956 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Eliem Therapeutics Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -34.87% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4.75 USD |
| 52 Week Low | 2.21 USD |
| 50-Day Moving Average | 3.09 USD |
| 200-Day Moving Average | 3.17 USD |
ELYM Share Statistics
| Avg. Volume (3 month) | 6.46K USD |
| Avg. Daily Volume (10-Days) | 2.4K USD |
| Shares Outstanding | 26.99M |
| Float | 4.45M |
| Short Ratio | 8.78 |
| % Held by Insiders | 26.64% |
| % Held by Institutions | 68.46% |
| Shares Short | 37.26K |
| Short % of Float | 0.45% |
| Short % of Shares Outstanding | 0.13% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -17.42% |
| Return on Equity (ttm) | -39.94% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -54330000 USD |
| Diluted EPS (ttm) | -2.22 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 109.37M USD |
| Total Cash Per Share (mrq) | 4.05 USD |
| Total Debt (mrq) | 687K USD |
| Total Debt/Equity (mrq) | 0.59 USD |
| Current Ratio (mrq) | 24.45 |
| Book Value Per Share (mrq) | 4.332 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -41767000 USD |
| Levered Free Cash Flow (ttm) | -12608750 USD |
Profile of Eliem Therapeutics
| Country | United States |
| State | WA |
| City | Redmond |
| Address | 23515 NE Novelty Hill Road |
| ZIP | 98053 |
| Phone | 877 354 3689 |
| Website | https://eliemtx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 30 |
Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its lead drug candidate is ETX-123, a Kv7.2/3 potassium channel opener, which is in preclinical for the treatment of neuronal excitability disorders, such as epilepsy, pain, depression, and others; and ETX-155 for the treatment of major depressive disorder and focal onset seizures that is in Phase 2a clinical trial. The company was incorporated in 2018 and is headquartered in Redmond, Washington.
Q&A For Eliem Therapeutics Stock
What is a current ELYM stock price?
Eliem Therapeutics ELYM stock price today per share is 4.31 USD.
How to purchase Eliem Therapeutics stock?
You can buy ELYM shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Eliem Therapeutics?
The stock symbol or ticker of Eliem Therapeutics is ELYM.
Which industry does the Eliem Therapeutics company belong to?
The Eliem Therapeutics industry is Biotechnology.
How many shares does Eliem Therapeutics have in circulation?
The max supply of Eliem Therapeutics shares is 27.72M.
What is Eliem Therapeutics Price to Earnings Ratio (PE Ratio)?
Eliem Therapeutics PE Ratio is now.
What was Eliem Therapeutics earnings per share over the trailing 12 months (TTM)?
Eliem Therapeutics EPS is -1.3 USD over the trailing 12 months.
Which sector does the Eliem Therapeutics company belong to?
The Eliem Therapeutics sector is Healthcare.
Eliem Therapeutics ELYM included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}